From the field
How Sightsavers celebrated World Sight Day
To mark World Sight Day 2019 on 10 October, Sightsavers country offices celebrated by highlighting the need to provide good-quality eye care to everyone.
“That lady who was going blind? Look at her now!”
In northern Kenya, Sightsavers’ Sarah Filbey visits an eye camp that treats both trachoma and cataracts, ensuring everyone gets the life-changing help they need.
Halving blindness in the remote Sundarbans
In this rural mangrove region of eastern India, one in 50 people used to be blind. But a Sightsavers project has transformed eye health in the area, changing thousands of lives.
Eye care for everyone in India
Sightsavers India is partnering with hospitals, tapping into existing eye care systems and creating new ones to provide affordable eye care for people living in some of the poorest areas of the country.
Roadside eye care: helping Indian truckers stay safe behind the wheel
Sightsavers' Kate McCoy spent three days at a noisy roadside truck stop to see how Sightsavers is helping truck drivers to get the vital eye treatment they need.
“I want to be able to dance again”
Sightsavers’ Katya Mira witnessed the first round of eye operations in Benin to treat blinding trachoma, and saw three women’s lives transformed.
September updates: highlights from around the world
News from India, featuring a Sightsavers-supported judoka who won a bronze medal at a Commonwealth competition. Plus the latest from Kenya, Zimbabwe, Tanzania and Zambia.
A childhood restored and a future secured
In eastern Zambia, Sightsavers’ Corinna May met nine-year-old Lovemore and saw his amazing transformation following sight-saving cataract surgery.
August updates: highlights from around the world
A round-up of the latest work that your donations help to support, including news from Nigeria, Mozambique, Pakistan and India.
How our research is finding new ways to fight river blindness
For more than 20 years, medication has been distributed in Cameroon to stop the spread of river blindness. Yet people are still testing positive for the disease. We wanted to know why.
